Safety and Efficacy Analysis of FRED™/FRED™Jr Embolic Device in Aneurysm Treatment

NCT03423290 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 61

Last updated 2022-04-29

No results posted yet for this study

Summary

A prospective, multicenter, observational evaluation of the safety and efficacy of the FRED® device in the treatment of intracranial aneurysms

Conditions

  • Intracranial Aneurysm

Interventions

DEVICE

FRED and FRED Jr

Flow Re-Direction Endoluminal Device

Sponsors & Collaborators

  • Clinact

    collaborator OTHER
  • Microvention-Terumo, Inc.

    lead INDUSTRY

Principal Investigators

  • Kyriakos Lobotesis, MD · Imperial College Healthcare NHS Trust

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-23
Primary Completion
2021-09-30
Completion
2022-01-26

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03423290 on ClinicalTrials.gov